Lifevantage (NASDAQ: LFVN) reported Q4 EPS of $0.01, $0.13 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $50.9 million versus the consensus estimate of $49.64 million.

GUIDANCE:

Lifevantage sees FY2023 EPS of $0.27-$0.39. Lifevantage sees FY2023 revenue of $200-212 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.